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Abstract
Background: HIV infection is linked to decreased fertility and fertility desires in sub-Saharan Africa due to biological
and social factors. We investigate the relationship between HIV infection and fertility or fertility desires in the
context of universal access to antiretroviral therapy introduced in 2004 in Rwanda.
Methods: We used data from 3532 and 4527 women aged 20–49 from the 2005 and 2010 Rwandan Demographic
and Health Surveys (RDHS), respectively. The RDHSs included blood-tests for HIV, as well as detailed interviews
about fertility, demographic and behavioral outcomes. In both years, multiple logistic regression was used to assess
the association between HIV and fertility outcomes within three age categories (20–29, 30–39 and 40–49 years),
controlling for confounders and compensating for the complex survey design.
Results: In 2010, we did not find a difference in the odds of pregnancy in the last 5 years between HIV-seropositive
and HIV-seronegative women after controlling for potential biological and social confounders. Controlling for the
same confounders, we found that HIV-seropositive women under age 40 were less likely to desire more children
compared to HIV-seronegative women (20–29 years adjusted odds ratio (AOR) = 0.31, 95% CI: 0.17, 0.58; 30–39 years
AOR = 0.24, 95% CI: 0.14, 0.43), but no difference was found among women aged 40 or older. No associations between
HIV and fertility or fertility desire were found in 2005.
Conclusions: These findings suggest no difference in births or current pregnancy among HIV-seropositive and
HIV-seronegative women. That in 2010 HIV-seropositive women in their earlier childbearing years desired fewer
children than HIV-seronegative women could suggest more women with HIV survived; and stigma, fear of
transmitting HIV, or realism about living with HIV and prematurely dying from HIV may affect their desire to
have children. These findings emphasize the importance of delivering appropriate information about pregnancy and
childbearing to HIV-infected women, enabling women living with HIV to make informed decisions about their
reproductive life.
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Plain English summary
HIV infection is linked to decreased fertility and fertility
desires in sub-Saharan Africa due to biological and social
factors. We investigate the relationship between HIV
infection and fertility or fertility desires in the context of
universal access to antiretroviral therapy introduced in
2004 in Rwanda. In 2010, we did not find a difference in
the odds of pregnancy between HIV-seropositive and
HIV-seronegative women. We did, however, find that
HIV-seropositive women under age 40 were less likely to
desire more children compared to HIV-seronegative
women. No associations between HIV and fertility or
fertility desire were found in 2005. These findings sug-
gest no difference in births or current pregnancy among
HIV-seropositive and HIV-seronegative women, but that
stigma, fear of transmitting HIV, or realism about living
with HIV and prematurely dying may affect desire to
have children among women under age 40. These find-
ings emphasize the importance of delivering appropriate
information about pregnancy and childbearing to HIV-
infected women, enabling women living with HIV to
make informed decisions about their reproductive life.
Background
Infection with HIV has been linked to decreased fertility
and fertility desires in sub-Saharan Africa due to both
biological and social factors. Established HIV infection,
typically occurring in older women, can compromise a
woman’s ability to become pregnant or successfully carry
a baby as a result of HIV-associated illnesses, fetal loss,
reduced coital frequency, reduced spermatogenesis of
the partner, and death of a partner [1, 2]. Furthermore,
prior to wide availability of antiretroviral therapy (ART),
clinicians were skeptical about encouraging HIV infected
women to have children due to shortened life expectancy
for the woman and high risk of HIV transmission to the
child [3]. HIV infected women were also discouraged by
families and communities from having children [4].
The advent of national HIV care and treatment programs
that target the general HIV population and pregnant
women may mediate the relationship between HIV infec-
tion and fertility. It is likely that ART removes biological
barriers for an HIV infected woman to become a mother
by reducing HIV associated illnesses [5, 6]. Importantly,
the risk of HIV mother-to-child transmission (MTCT) has
also been drastically decreased with national prevention of
MTCT (PMTCT) programs [7]. Due to increased availabil-
ity and knowledge of PMTCT programs which include
family planning, there is wider support for HIV infected
women to have children [4]. However, to date, there is little
published research on fertility and fertility preferences of
HIV infected women as compared to their uninfected
counterparts in the context of expanded ART and PMTCT
programs [1].
In Rwanda, the national HIV care and treatment pro-
gram was introduced in 2004 and policies for eligibility
for ART and PMTCT have evolved over time (Fig. 1).
The percentage of HIV seropositive women receiving
ART during pregnancy to reduce the risk of MTCT in
Rwanda has increased from 10% in 2004 to 64% in 2012
[8, 9]. Between 2001 and 2009, the mortality rate from
HIV/AIDS in Rwanda was reduced by 50% or more
across all age groups [Unpublished epidemiological
population projections from UNAIDS Spectrum, 2014]
and HIV incidence was reduced by more than 25% [9].
The Rwanda 2010 national guideline for clinical
Fig. 1 Evolution of the Rwanda HIV Antiretroviral Therapy and Prevention of Mother to Child Transmission Programs
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prevention of HIV/AIDS recommends voluntary HIV
testing during antenatal care visits of pregnant women,
and encourages testing and receipt of results together
for couples. As a result, 98.2% of pregnant women were
tested and received HIV results in 2010, and among them,
84% were tested and received results as a couple [10].
Major campaigns to get tested for HIV resulted in a
more than threefold increase in the number of women
who knew their status between 2005 and 2010 [10].
In 2010, an estimated 80% of eligible individuals were
on ARTand 83% of HIV infected pregnant women were
receiving prophylaxis to reduce MTCT in PMTCT
[10]. The goal of this paper is to examine the rela-
tionship between HIV infection and fertility in the
context of expanded national ART and PMTCT programs
in Rwanda.
Methods
Study population and design
Our primary analysis uses data from the 2010 RDHS
[11] to assess the relationship between HIV and fertility
among women in Rwanda. The 2010 RDHS is a nation-
ally representative cross-sectional household survey of
13,671 women (15 to 49 years) and 6329 men (15 to
59 years) from 492 villages in Rwanda. The survey used
a two-stage sampling design to produce separate esti-
mates of key indicators for each of the 30 districts of
Rwanda. All women aged 15 to 49 who were either per-
manent residents of the household or visitors in the
household on the night before the survey were eligible
to be interviewed.
In the 2010 RDHS, HIV testing was offered to 6952
eligible women, 99% of whom consented. Questions
about fertility, however, were only asked to women who
self-reported ever having sex and not being infertile.
Fertility in women under age 20 (41 births per 1000
women) is much lower and influenced by legal age of
marriage (21 years in Rwanda), secondary school attend-
ance, and other factors not applicable to woman age 20
to 24 (189 births per 1000 women) and older [11], thus
this analysis excluded women less than 20 years of age.
The final analysis included the 4527 women who
consented to HIV testing, responded to the fertility
questions, and were aged 20 or older (Fig. 2).
For a secondary analysis, the 2005 RDHS [12] was
used to evaluate if the relationship between HIV and
fertility changed between 2005 and 2010 which would
provide evidence of unmeasured factors, such as ART
scale up, changing between these two points in time.
The 2005 RDHS was collected using the same methods
as the 2010 RDHS. The 2005 RDHS included 11,539
women (15 to 49 years), and HIV testing was offered to
5663 women with 98.8% consent rate, resulting in 3532
women age 20 or older in the secondary analysis.
Variables and analysis
Two outcomes were explored. The first outcome of
interest was fertility in the last 5 years defined as having
given birth in the last 5 years or currently being preg-
nant. The second outcome of interest was a desire to
have more children, defined as a woman reports that
she would like to have a (another) child. A literature re-
view and development of a conceptual framework in-
formed key variables to include in this analysis (Fig. 3).
Socio-demographic variables included in the analysis
were wealth index, urban/rural residence, family size, pol-
ygamous marriage, woman’s educational level, and
woman’s employment status. Clinical and behavioral data
for the women included HIV status, knowledge of MTCT,
number of lifetime sex partners, polygamous marriage,
current use of contraception, and fertility more than
5 years ago. Variables identified in the conceptual frame-
work that were not available in the dataset included type
and timing of past sexually transmitted infection (STI),
knowledge of HIV status, and use of antiretroviral therapy.
Fig. 2 Flow chart of individuals included in the analyses of 2005
and 2010 (unweighted)
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Only those variables which changed the coefficient of the
primary predictor, HIV status, in one or more age group
by 10% or more were considered for the final model as a
potential confounder.
HIV prevalence, fertility in the last 5 years, and desire
to have more children were estimated with 95%
confidence intervals for all covariates and chi-square
tests were used to describe differences between groups.
Multiple logistic regression models were used to assess
the association between HIV and each of the two out-
comes. Since fertility patterns and drivers change over
the life course, the effect of HIV was modeled in three
separate age groups: 20–29, 30–39 and 40–49 years by
including an interaction term of HIV status and age
group. All potential confounders that were not collin-
ear (r<=|0.7|) were included in the final multivariable
model, and records with any missing data were dropped.
We assessed each covariate for confounding the primary
effects, and included it in the final model if it changed
the effect of HIV within any age group by 10% or more.
Models were built for each outcome separately.
For the secondary analysis, we produced multivariable
regression models for 2005 as a comparison and presented
adjusted odds ratios (AOR). In these 2005 models, we
controlled for the same confounders identified in the 2010
analysis to ensure comparability. All analyses were com-
pleted in Stata v12 using the svy commands to account for
sample weights, clustering of households, and stratifica-
tion by district (2010) or province (2005).
Ethics
For both the 2005 and 2010 RDHS, informed consent was
obtained from every study participant before the start of
the interview, and a second consent was obtained before
blood draw to test for HIV. The RDHS received ethical
approval from the Rwandan National Ethics Committee
and the US Centers for Disease Control and Prevention
(CDC). We received permission from the MeasureDHS
project to download and use these data for this analysis.
Results
The overall prevalence of HIV in 2010 was 5.2% (95%
CI: 4.6%, 6.0%) (Table 1). In the bivariate analysis, both
fertility in the last 5 years and desire for more children
were significantly associated with HIV (p < 0.001;
Table 2). Significantly higher rates of HIV were observed
among women who had at least a secondary education,
were employed, had higher household wealth, knew
about MTCT, or lived in urban areas. Women with an
unmet need for contraception and women who had a
larger number of births more than 5 years ago had a
lower prevalence of HIV (Table 2).
Overall, seventy two percent (72.1%) of the women in
2010 (95% CI: 70.6%, 73.6%) had at least one birth in the
last 5 years or were currently pregnant, and 45.8% (95%
CI: 44.3%, 47.3%) desired to have more children
(Table 2). In bivariate analysis, HIV seropositive women
were less likely to have given birth to a child in the last
5 years or be pregnant (54.3%, 95% CI: 47.9%, 60.6%)
and less likely to desire children in the future (30.5%,
95% CI: 24.6%, 37.2%) compared to HIV seronegative
women (73.1%, 95% CI: 71.5%, 74.6%; and 46.6%, 95%
CI: 45.1%, 48.2%, respectively). The factors significantly
associated with recent fertility in the bivariate analysis
were: age group, residence, education, employment,
wealth group, number of lifetime sex partners,
Fig. 3 Conceptual framework
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polygamous marriage, fertility more than 5 years prior to
the survey, age at first sex, ever had a terminated preg-
nancy, every had a death of a child under 5, current use
of a modern method of contraception, unmet need for
contraception, knowledge of MTCT, and desire for more
children (Table 2). The factors significantly associated
with the desire for more children in the bivariate ana-
lysis were: age group, residence, education, employment,
wealth group, number of lifetime sex partners, polygam-
ous marriage, fertility more than 5 years prior to the sur-
vey, age at first sex, ever had a terminated pregnancy,
ever had a death of a child under 5, has an unmet need
for contraception, had a birth in the last 5 years or is
currently pregnant.
After controlling for covariates and applying an inter-
action term between HIV and age group, fertility no
longer differed statistically between HIV seropositive and
HIV seronegative women (Table 3). The odds of having
a recent birth or being pregnant was lower but non-
significant in younger infected women (20–29, 30–
39 years) compared to their uninfected counterparts. In
regression analysis, HIV seropositive women were less
likely to desire more children compared to uninfected








Overall 4549 5.2 [4.6,6.0] –
Fertility in the last 5 years





No more, sterilized 2466 6.7 [5.7,7.8] <0.001
Want another, undecided 2083 3.5 [2.7,4.5]
Age group
20–29 1903 4.2 [3.4,5.3] 0.037
30–39 1541 6.0 [4.9,7.3]
40–49 1105 5.9 [4.7,7.5]
Residence
Urban 681 12.2 [9.9,14.9] <0.001
Rural 3868 4.0 [3.4,4.7]
Education
Less than secondary 4036 4.8 [4.1,5.5] <0.001
Secondary or higher 513 9.0 [6.9,11.7]
Employmenta
Not working, farmer 3860 4.4 [3.7,5.1] <0.001
Employed 681 10 [8.0,12.5]
Wealth group
Bottom 2 quintiles 1847 4.5 [3.6,5.7] <0.001
Middle quintile 889 3.5 [2.4,5.0]
Top 2 quintiles 1813 6.8 [5.7,8.2]
Number of lifetime sex partnersa
1 partner 3247 3.0 [2.5,3.7] <0.001
2–4 partners 1257 10.1 [8.4,12.1]
5+ partners 42 30.1 [17.6,46.3]
Polygamous marriagea
No 3109 3.3 [2.8,4.0] <0.001
Yes 267 5.9 [3.5,9.6]
Not married 1158 10.1 [8.5,12.0]
Fertility more than 5 years ago
No birth 361 4.3 [2.5,7.2] <0.001
1–3 births 1297 7.7 [6.3,9.5]
4–6 births 1820 4.9 [4.0,5.9]
7+ births 1071 3.1 [2.2,4.4]
Age at first sexa
< 21 2748 60.5 [58.9,62.0] 0.039
21–24 1352 29.8 [28.4,31.2]
25+ 444 9.8 [8.9,10.7]
Table 1 HIV prevalence in Rwanda by background characteristic,
2010 (Continued)
Ever had a terminated pregnancya
No 3725 5.3 [4.6,6.1] 0.858
Yes 822 5.1 [3.8,6.8]
Ever had a death of child under 5
No death 3164 4.6 [3.9,5.4] 0.008
Lost one or more
children under 5
1385 6.7 [5.3,8.4]
Current use of modern method of contraception
No 2825 5.2 [4.4,6.2] 0.965
Yes 1724 5.3 [4.2,6.5]
Has an unmet need for contraceptiona
No 3792 5.7 [5.0,6.5] 0.002
Yes 754 3.0 [2.0,4.5]
Knows of a modern contraceptive methoda
No 7 12.8 [1.7,56.2] 0.356
Yes 4541 5.2 [4.6,6.0]
Knowledge of MTCTa
No 326 2.5 [1.2,4.8] 0.019
Yes 4191 5.5 [4.8,6.3]
Comprehensive knowledge of HIV/AIDS
No 1957 4.2 [3.5,5.2] 0.003
Yes 2592 6.0 [5.1,7.0]
aCategories may not sum to 100% due to missing data
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Table 2 Distribution of fertility in the last 5 years and desire to have more children in Rwanda by background characteristic, 2010
Fertility in the last 5 years Desire more children
Characteristic n (weighted) Percent 95% CI X2 p-value Percent 95% CI X2 p-value
Overall 4549 72.1 [70.6,73.6] 45.8 [44.3,47.3]
HIV status
Negative 4311 73.1 [71.5,74.6] <0.001 46.6 [45.1,48.2] <0.001
Positive 238 54.3 [47.9,60.6] 30.5 [24.6,37.2]
Age group
20–29 1903 86.4 [84.4,88.2] <0.001 76.3 [74.4,78.2] <0.001
30–39 1541 76.7 [74.4,78.9] 33.3 [30.7,35.9]
40–49 1105 40.9 [38.0,43.9] 10.6 [8.9,12.6]
Residence
Urban 681 63.2 [58.9,67.3] <0.001 51.9 [47.8,56.1] 0.002
Rural 3868 73.6 [72.0,75.2] 44.7 [43.1,46.3]
Education
Less than secondary 4036 73.3 [71.8,74.8] <0.001 44.5 [43.0,46.1] <0.001
Secondary or higher 513 62.4 [57.6,66.9] 55.5 [51.0,59.9]
Employmenta
Not working, farmer 3860 74.0 [72.4,75.5] <0.001 44.0 [42.4,45.7] <0.001
Employed 681 61.9 [57.9,65.7] 55.7 [51.6,59.7]
Wealth group
Bottom 2 quintiles 1847 76.8 [74.8,78.8] <0.001 41.9 [39.5,44.4] <0.001
Middle quintile 889 73.3 [69.9,76.5] 47.4 [44.1,50.7]
Top 2 quintiles 1813 66.6 [64.2,69.0] 48.9 [46.4,51.4]
Number of lifetime sex partnersa
1 partner 3247 74.8 [73.1,76.5] <0.001 48.9 [47.2,50.7] <0.001
2–4 partners 1257 66.2 [63.5,68.9] 37.7 [34.8,40.7]
5+ partners 42 35.5 [22.3,51.3] 44.2 [29.1,60.6]
Polygamous marriagea
No 3109 81.3 [79.7,82.7] <0.001 48.3 [46.5,50.1] <0.001
Yes 267 72.7 [67.0,77.8] 29.8 [24.5,35.7]
Not married 1158 47.4 [44.4,50.4] 43.0 [44.3,47.4]
Fertility more than 5 years ago
No birth 361 29.9 [24.9,35.4] <0.001 96.0 [93.5,97.6] <0.001
1–3 births 1297 71.1 [68.4,73.7] 71.4 [68.6,74.0]
4–6 births 1820 76.7 [74.6,78.6] 37.4 [35.0,39.9]
7+ births 1071 79.6 [76.9,82.1] 12.1 [10.4,14.2]
Age at first sexa
< 21 2748 58.9 [57.0,60.8] <0.001 41.1 [39.2,43.0] <0.001
21–24 1352 48.7 [46.0,51.5] 51.3 [48.5,54.0]
25+ 444 42.0 [37.4,46.8] 58.0 [53.2,62.6]
Ever had a terminated pregnancya <0.001 <0.001
No 3725 73.6 [72.0,75.2] 48.4 [46.7,50.0]
Yes 822 65.0 [61.6,68.3] 34.1 [30.8,37.5]
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women among 20 to 29 year olds (AOR = 0.31, 95% CI:
0.17, 0.58) and 30 to 39 years (AOR = 0.24, 95% CI: 0.14,
0.43). There were no differences in desire for more chil-
dren among women age 40 to 49 (AOR = 1.57, 95% CI:
0.75, 3.27, Table 3).
When the same models were run with the 2005 data,
no associations were identified between HIV status and
fertility in the last 5 years in any age group (Table 4).
There were no associations between births in the last
5 years and HIV status (20–29 years: AOR = 0.43, 95%
CI: 0.13, 1.51; 30–39 years: AOR = 1.33, 95% CI: 0.62,
2.84; and 40–49 years: AOR = 1.35, 95% CI: 0.63, 2.91).
Similarly, we did not identify association between HIV
status and desire for more children (20–29 years: AOR
= 0.62, 95% CI: 0.30, 1.28; 30–39 years: AOR = 0.72, 95%
CI: 0.44, 1.19; and 40–49 years: AOR = 0.90, 95% CI:
0.36, 2.26).
Discussion
The relationship between HIV status and women’s fertil-
ity is complex, both biologically and behaviorally. These
Table 2 Distribution of fertility in the last 5 years and desire to have more children in Rwanda by background characteristic, 2010
(Continued)
Ever had a death of child under 5
No death 3164 73.5 [71.7,75.2] <0.001 53.9 [52.1,55.8] <0.001
Lost one or more children under 5 1385 68.8 [66.2,71.2] 27.2 [24.8,29.7]
Current use of modern method of contraception
No 2825 65.3 [63.2,67.2] <0.001 46.6 [44.6,48.6] 0.212
Yes 1724 83.3 [81.3,85.1] 44.5 [42.1,46.9]
Has an unmet need for contraceptiona
No 3792 67.7 [66.0,69.3] <0.001 47.8 [46.1,49.4] <0.001
Yes 754 94.1 [92.1,95.6] 35.8 [32.3,39.5]
Knows of a modern contraceptive methoda
No 7 40.0 [10.3,79.4] 0.101 70.9 [30.2,93.2] 0.207
Yes 4541 72.1 [70.6,73.6] 45.7 [44.2,47.3]
Knowledge of MTCTa
No 326 65.7 [59.9,71.0] 0.011 43.4 [38.3,48.6] 0.374
Yes 4191 72.8 [71.2,74.4] 45.9 [44.3,47.5]
Comprehensive knowledge of HIV/AIDS
No 1957 72.9 [70.6,75.0] 0.350 45.2 [43.1,47.4] 0.537
Yes 2592 71.5 [69.5,73.4] 46.2 [44.1,48.3]
Desire more children
No more, sterilized 2466 67.4 [65.4,69.3] <0.001
Want another, undecided 2083 77.6 [75.4,79.7]
Birth in the last 5 years, or pregnant
No children 1270 36.7 [33.8,39.7] <0.001
1–4 children or pregnant 3279 49.3 [47.5,51.1]
aCategories may not sum to 100% due to missing data
Table 3 Effect of HIV status on fertility and desire of more
children in Rwanda, 2010




AOR 95% CI AOR 95% CI
Age 20–29 HIV- Ref Ref
HIV+ 0.83 [0.42, 1.65] 0.31 [0.17, 0.58]
Age 30–39 HIV- Ref Ref
HIV+ 0.60 [0.35, 1.03] 0.24 [0.14, 0.43]
Age 40–49 HIV- Ref Ref
HIV+ 1.13 [0.48, 2.67] 1.57 [0.75, 3.27]
n 4501 4466
aConfounders controlled for: Woman’s employment, woman’s education,
number of lifetime sex partners, polygamous marriage, household wealth,
urban/rural residence, had a death of a child under 5, unmet need for
contraception, desire more children
bConfounders controlled for: Woman’s employment, woman’s education,
number of lifetime sex partners, polygamous marriage, household wealth,
urban/rural residence, age at first sex, ever terminated a pregnancy,
knowledge of MTCT, had a death of a child under 5, use of contraception,
unmet need for contraception, birth in the last 5 years or pregnant
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secondary analyses have shown that, after controlling for
other factors in the multiple logistic regression models,
the differences in fertility for the last 5 years between
HIV seropositive women as compared to seronegative
women were not statistically significant. However, the
desire for more children in the future is lower among
HIV seropositive women aged 20 to 39 compared to
HIV seronegative women in Rwanda in 2010.
The relationship between HIV and fertility
The literature about the relationship between HIV infec-
tion and fertility is conflicting. The notion that HIV
would lead to a stark decrease in fertility has been chal-
lenged by evidence that HIV infected women actually
have more children than their HIV seronegative peers
[13]. A study conducted in Kenya in 2010 showed an
increase in fertility in HIV infected women due to an
increased mortality in children which led HIV infected
women to have more children [14]. However, the
increase in fertility in HIV seropositive women may only
be true for those women who are still in the early stage
of their infection. There is increasing evidence suggest-
ing that HIV infected women, particularly women with
advanced HIV infections or AIDS, are less fertile than
HIV uninfected women [15].
One possible explanation for no significant association
between HIV and fertility in 2010 is the scale-up of
ART. In Rwanda, it was estimated that 85% of HIV
infected adults in need were on ART in 2010 (compared
to 44% in 2005), and the median CD4 cell count at ART
initiation among adult patients increased from 153 cells/
mm3 in 2005 to 277 cells/mm3 in 2010 [Unpublished
dissertation by Dr. Jean Pierre Nyemazi (2012)
Outcomes of adult patients on Antiretroviral Therapy
from 2004 to 2010 in National University of Rwanda,
School of Public Health]. Thus expanded access to ART
in Rwanda may explain the lack of significant differences
in fertility that we observed in this analysis. Recent stud-
ies have reported an independent effect of ART on in-
creasing pregnancy incidence over time in women on
treatment compared with ART-naıve women [5, 6, 16]. In
several settings where antiretroviral therapy has been
scaled-up, pregnancy and births rates among HIV sero-
positive women have significantly increased [17]. The
improved individual health through the availability of
ART may result in improved sexual drive, influencing
the behavior of HIV seropositive women [18]. Women
on treatment may feel healthier, more optimistic
about the PMTCT interventions, more positive about
their own and children’s futures, and therefore engage
in unprotected sexual activity and be more inclined
to become pregnant [19].
Another possible explanation for the lack of a signifi-
cant difference in fertility between HIV seropositive and
HIV seronegative women in 2010 is the emphasis that
Rwanda has put on promoting access and use of family
planning services. Over the last 10 years, the country ex-
perienced a remarkable increase in modern contracep-
tive use. The contraceptive prevalence rate increased
from 17 to 52% between 2005 and 2010 [11, 12]. Unmet
need for family planning declined from 38 to 19%. The
infant mortality rate has decreased from 105 deaths to
50 deaths per 1000 live births, and the total fertility rate
dropped from 6.1 to 4.6 births [12, 20]. Thus in addition
to increased fertility of HIV seropositive women, there
may also be a greater drop in fertility among HIV sero-
negative women due to use of modern contraceptive
methods.
A third potential explanation is that there is no
relationship between HIV and fertility in Rwanda, which
is supported by the results of the 2005 analysis. How-
ever, given the large improvements in survival with HIV,
the lack of relationship in 2005 is likely influenced by
survivor bias; women who were so sick they could not
or chose not be become pregnant did not survive to be
measured.
The relationship between HIV and the desire for more
children
HIV infected women between 20 and 39 years of age
were significantly less likely to want more children in
the future than those not infected with HIV in 2010.
This was similarly shown in some studies [21, 22], but
not all [23]. There are several hypotheses for this find-
ing. In the context of high service coverage, women in-
fected with HIV have monthly contact with the health
system through pre-ART or ART care to obtain
Table 4 Effect of HIV status on fertility and desire of more
children in Rwanda, 2005




AOR 95% CI AOR 95% CI
Age 20–29 HIV- Ref Ref
HIV+ 0.43 [0.13, 1.51] 0.62 [0.30, 1.28]
Age 30–39 HIV- Ref Ref
HIV+ 1.33 [0.62, 2.84] 0.72 [0.44, 1.19]
Age 40–49 HIV- Ref Ref
HIV+ 1.35 [0.63, 2.91] 0.90 [0.36, 2.26]
n 3524 3366
aConfounders controlled for: Woman’s employment, woman’s education,
number of lifetime sex partners, polygamous marriage, household wealth,
urban/rural residence, had a death of a child under 5, unmet need for
contraception, desire more children
bConfounders controlled for: Woman’s employment, woman’s education,
number of lifetime sex partners, polygamous marriage, household wealth,
urban/rural residence, age at first sex, ever terminated a pregnancy,
knowledge of MTCT, had a death of a child under 5, use of contraception,
unmet need for contraception, birth in the last 5 years or pregnant
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medication. Therefore, with integrated HIV care and
treatment services with family planning services, it is
highly conceivable that through regular contact with the
health system, infected women have increased awareness
about the benefits of spacing and small family sizes thus
decreasing their desire for more children. More research
is needed to explore the plausibility of this hypothesis.
A competing hypothesis is that the lower desire for
children among HIV seropositive women may be born
from stigma or fear. In other studies, reasons for HIV in-
fected women not wanting another child included the
need to provide for their living children; fear that their
poor health may prevent them from taking care of an
additional child; the fear of leaving the child orphaned;
the fear that they may not have any family support to
raise the child; the fact that they were not yet fully con-
vinced about the efficacy of antiretroviral triple therapy
in mitigating MTCT; and fear that the physical demands
of pregnancy and childbirth could negatively impact
their own health [18, 22, 24].
We did not observe a similar effect between HIV and
fertility desire in the 2005 secondary analysis. However,
this can reflect both survivor bias, since very few people
were on HIV treatment at the time, and the very low
prevalence of women who knew their HIV status at that
time (11.6%) [12].
Limitations
This study used data available through two recent
RDHSs. With the cross-sectional nature of the data col-
lection, it is impossible to ascertain the sequence of out-
comes and exposures, specifically the length of HIV
infection, whether or not a woman knew her infection
status (either at the time of the survey or the time of
pregnancy), and whether or not she was accessing HIV
care. Our hypothesis that access to ART contributed to
the non-significant difference in fertility rates between
HIV infected and HIV uninfected women relies on the
assumption that HIV infected women knew their status
and accessed HIV care and treatment services. This is
plausible in 2010 when an estimated 80% of eligible indi-
viduals in need were on ART, but tenuous in the full
5 years under study as these map to years of scale-up of
the ART program. The amount that ART is contributing
to non-differential fertility rates can be further explored
by repeating this analysis with the 2015 RDHS under-
way at the time of this analysis, and the 2013 Rwanda
AIDS indicator survey. The hypothesis that knowledge
of HIV status decreases desire for more children (either
through increased family planning knowledge or because
of stigma/fear) hinges on the assumption that a woman
knew her status at the time of the RDHS data collection.
This is a plausible assumption given that in 2010, 77.2% of
respondents had ever had an HIV test and 38.6% had a test
in the last 12 months [11]. Another limitation resulting
from use of secondary data was that not all variables con-
tributing to the relationship between HIV and fertility were
available. Specifically, data on past STIs and antiretroviral
therapy use are important confounders that were unavail-
able for this analysis. We recommend that future iterations
of the RDHS collect symptoms of common STIs to explore
these hypotheses further, though current DHS policy pre-
vents directly asking respondents to disclose HIV status by
naming use of ART.
Conclusion
Non-significant differences in fertility between infected
and uninfected women suggest progress in addressing
the health and social consequences of HIV. However,
significant differences in desire for more children remain
between these two groups. More research is needed to
understand the factors influencing fertility desires
among people living with HIV/AIDS and to test whether
the availability of expanded HIV services including Op-
tion B+ introduced in 2012 in Rwanda has changed the
fertility and fertility desires of HIV infected women.
After the 2015 RDHS is released, it will be important to
investigate changes in fertility and HIV between 2005,
2010, and 2015, as ART and PMTCT services expanded
to include universal access to treatment in the general
population and Option B+ for pregnant women.
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